| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396643 Screening sample for the presence of transcription factors; obtain nucleotide sequences, join to solid support, incubate with transcription factors, detect signal |
| 07/08/2008 | US7396545 Preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 07/08/2008 | US7396525 Care/makeup compositions comprising a 2-alkylideneaminooxyacetamide compound for stimulating the growth of the hair or eyelashes and/or slowing loss thereof |
| 07/08/2008 | CA2675451A1 Combination therapy with angiogenesis inhibitors |
| 07/08/2008 | CA2533061C Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2344090C Compositions and methods for treating female sexual dysfunction |
| 07/08/2008 | CA2339384C Improved method for targeted topical treatment of disease |
| 07/08/2008 | CA2317748C Use of antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection |
| 07/08/2008 | CA2298681C Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 07/08/2008 | CA2231509C Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 07/08/2008 | CA2198706C Methods for the treatment of inflammatory joint disease |
| 07/08/2008 | CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/08/2008 | CA2117782C Use of renin-angiotensin antagonist for reducing post myocardial infarct morbidity and mortality |
| 07/03/2008 | WO2008080092A2 Compositions comprising bile acid sequestrants for treating esophageal disorders |
| 07/03/2008 | WO2008079720A1 Alpha-2b receptor agonist and anticonvulsant compositions for treatng chronic pain |
| 07/03/2008 | WO2008079312A2 Compositions for treatment of nasal congestion |
| 07/03/2008 | WO2008079256A2 Methods for treating nasal congestion in hypertensive or diabetic patients |
| 07/03/2008 | WO2008078785A1 Klf5 suppressor and method for selecting active ingredient of the medicament |
| 07/03/2008 | WO2008078730A1 Preparation for transnasal application |
| 07/03/2008 | WO2008078715A1 Therapeutic agent for inflammatory myopathy containing il-6 antagonist as active ingredient |
| 07/03/2008 | WO2008078673A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 07/03/2008 | WO2008078420A1 Anti-arteriosclerotic agent |
| 07/03/2008 | WO2008077939A2 Duloxetine composition |
| 07/03/2008 | WO2008077772A2 Combination of a retinoid and a platinum anticancer agent |
| 07/03/2008 | WO2008077599A1 COMBINATION THERAPY OF LOWER URINARY TRACT DISORDERS WITH α2δ LIGANDS AND NSAIDS |
| 07/03/2008 | WO2008057298A3 Lipidized interferon and uses thereof |
| 07/03/2008 | WO2008046584A3 Lepa as a target for antibacterial agents |
| 07/03/2008 | WO2008027013A3 Combination of mtor antagonist and angiogenesis inhibitor for the treatment of cancer |
| 07/03/2008 | WO2008023362A3 Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer |
| 07/03/2008 | WO2007147613A3 Combinations comprising staurosprorines |
| 07/03/2008 | WO2007140299A3 Use of ixabepilone in combination with cyp3a4 inhibitors for pharmaceuticals |
| 07/03/2008 | WO2007119214A3 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 07/03/2008 | WO2007101357A3 Hair growth agent for the treatment of human keratin fibers, and method for the production thereof |
| 07/03/2008 | WO2007054783A3 Compositions and methods for treating thrombocytopenia |
| 07/03/2008 | US20080161603 Amino acid and peptide heteroconjugated disulfides of 2-mercaptoethane sulfonate sodium; side effect reduction; side effect reduction |
| 07/03/2008 | US20080161551 Carrageenan Based Antimicrobial Compositions |
| 07/03/2008 | US20080161525 reaction product of polystyrene bound mesna (mercaptoethanesulfonic acid, sodium salt) and a sulfur-containing amino acid, preferably cysteine; chemical intermediates; anticarcinogenic agent; side effect reduction; heteroconjugate |
| 07/03/2008 | US20080161426 p53 Inhibitors and Therapeutic Use of the Same |
| 07/03/2008 | US20080161424 Compositions and Methods for the Systemic Treatment of Arthritis |
| 07/03/2008 | US20080161419 Selective antagonistic compounds 5-HT2B and 5-HT7 receptors; reduced side effects |
| 07/03/2008 | US20080161416 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161415 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161414 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161410 Aminoalkanol Derivatives |
| 07/03/2008 | US20080161398 Stimulation of in vivo production of proteins |
| 07/03/2008 | US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution |
| 07/03/2008 | US20080161369 Open label, single arm, two stage, multicenter study; patients who have not responded to taxane/platinum therapy or have relapsed within six months |
| 07/03/2008 | US20080161353 8-Hydroxy quinoline derivatives |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161321 Use of Renin Inhibitors in Therapy |
| 07/03/2008 | US20080161287 Bicyclic compound, production and use thereof |
| 07/03/2008 | US20080161250 Topical treatment or prevention of ocular infections |
| 07/03/2008 | US20080160613 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/03/2008 | US20080160576 Anti-alphabeta3 humanized monoclonal antibodies |
| 07/03/2008 | US20080160121 Identifying an epileptogenic focus of a patient; and administering a botulinum toxin; direct infusion, circumventing the blood-brain barrier |
| 07/03/2008 | US20080160120 Lapactic agent |
| 07/03/2008 | US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects |
| 07/03/2008 | US20080160063 particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks |
| 07/03/2008 | US20080160041 C-type lectin specific monoclonal antibody conjugate for use in reducing immune response to specific antigens; immunotherapy; immunosuppression; treating allergies and autoimmune diseases |
| 07/03/2008 | US20080160029 Treatment with anti-vegf antibodies |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160016 Compositions and methods of tolerizing a primate to an antigen |
| 07/03/2008 | US20080160006 Nutrient broth for maintenance of brain or spinal cord tissue |
| 07/03/2008 | US20080159988 Materials and methods for treating or preventing oxalate-related disease |
| 07/03/2008 | US20080159980 Glutathione s-transferase (GST); kits |
| 07/03/2008 | DE112005000730T5 Ionen bindende Polymere und ihre Verwendung Ion-binding polymers and their use |
| 07/03/2008 | CA2673616A1 Alpha-2b adrenergic receptor agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain |
| 07/03/2008 | CA2673606A1 Alpha-2b receptor agonist and anticonvulsant compositions for treatng chronic pain |
| 07/03/2008 | CA2673545A1 Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids |
| 07/02/2008 | EP1939300A1 Methods and compositions for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders |
| 07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1938841A2 Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof |
| 07/02/2008 | EP1938840A1 Duloxetine composition |
| 07/02/2008 | EP1938839A1 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 07/02/2008 | EP1938838A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 07/02/2008 | EP1938837A1 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| 07/02/2008 | EP1938816A2 Compounds and methods for inducing apoptosis in cancer cells |
| 07/02/2008 | EP1938814A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 07/02/2008 | EP1938811A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 07/02/2008 | EP1938799A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 07/02/2008 | EP1937265A2 Comination of a hypnotic agent and r(+)-alpha-(2,3-dimethoxy-phenyl)-1-[2-(4-fluorophenl)ethyl]-4-piperidinemethanol and therapeutic application thereof |
| 07/02/2008 | EP1937264A2 Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| 07/02/2008 | EP1937255A2 Pharmaceutical composition |
| 07/02/2008 | EP1937244A2 Treatment of cancer with specific rxr agonists |
| 07/02/2008 | EP1937229A2 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions |
| 07/02/2008 | EP1660100B1 Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
| 07/02/2008 | EP1471916B1 Treatment of rheumatoid arthritis using imatinib |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1451181B1 Dimeric compounds and their use as anti-viral agents |
| 07/02/2008 | EP1333828B1 Prevention of development of dyskinesias |
| 07/02/2008 | EP1141003B9 Methods of activation of SGK by phosphorylation. |
| 07/02/2008 | EP1119349B1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 07/02/2008 | CN101212986A Stable emulsion composition |
| 07/02/2008 | CN101212985A Kinin antagonists for treating bladder dysfunction |